Lauren Hindman
As a patient in our Center for Young Adult Colorectal Cancer, Lauren has formed a close relationship with her surgeon, Motaz Qadan, MD, PhD, and together they have navigated the impact this disease has had on Lauren.
About Motaz Qadan, MD, PhD
Motaz Qadan, MD, PhD, is a hepatobiliary and pancreatic surgical oncologist at the MGH. He is a high volume pancreas and liver specialized surgeon with excellent outcomes. He is surgical director of the Mass General Cancer Center and Section Head of the Hepatobiliary/Liver Program at the MGH. Patient information videos about his common operations are included below:
Dr. Qadan's leadership positions include:
- Hepatic Arterial Infusion Pump Program Director
- Pancreas Cyst Clinic Director
- Hepatobiliary Surgery Director for Young Adult Colorectal Cancer Center
- Harvard Medical Student Advanced Surgical Clerkship Director
- Mass General Brigham Resident and Fellow Wellbeing Council Faculty Advisor
- Clinical Lead for Enhanced Recovery after Surgery (ERAS) in Pancreas Surgery
- Clinical Lead for Robotic Hepatobiliary and Pancreatic Surgery
Dr. Qadan received his undergraduate and medical degrees from the University of Edinburgh Medical School, which is among the top medical schools in Western Europe. He completed surgical residency at Stanford University, where he served as administrative chief resident. Following this, he completed a fellowship in complex general surgical oncology at the Memorial Sloan Kettering Cancer Center in New York where he served as the educational coordinator.
Dr. Qadan is also a Fellow of the American College of Surgeons (FACS) and a Member of the Royal College of Surgeons of Edinburgh (MRCSEd). He is a surgical member of the multidisciplinary cancer team at the MGH.
Below are some additional sites of interest:
Departments, Centers, & Programs:
Clinical Interests:
- Hepatic Arterial Pump
- Hepatocellular carcinoma, Cholangiocarcinoma, Liver tumors
- Liver cancer
- Liver metastases
- Liver surgery
- Minimally invasive surgery
- Pancreatic and hepatobiliary surgery
- Pancreatic cancer
- Pancreatic cystic tumors
- Pancreatobiliary surgery
- Robotic surgery
- Surgical oncology
Treats:
- Adult
Locations
Boston: Massachusetts General Hospital
Massachusetts General Hospital
55 Fruit St.
Boston, MA 02114
Phone: 617-643-5153
Medical Education
- MD, University of Edinburgh
- Fellowship, Memorial Sloan Kettering Cancer Center
American Board Certifications
- Complex General Surgical Oncology, American Board of Surgery
- Surgery, American Board of Surgery
Accepted Insurance Plans
- Aetna
- Beech Street
- Blue Cross Blue Shield
- Blue Cross Blue Shield Medicare
- Cigna
- Commonwealth Care Alliance
- Coventry
- Fallon Health
- Harvard Pilgrim Health Care
- Humana
- Mass General Brigham Health Plan
- MassHealth
- Medicaid CT
- Medicaid ME
- Medicaid NH
- Medicaid RI
- Medicaid VT
- Medicare
- Medicare ACO
- Multiplan
- Senior Whole Health
- TriCare
- Tufts Health Plan
- United Health Care
- Wellpoint
- WellSense
- WellSense NH
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
The Qadan laboratory focuses on the tumor microenvironment in pancreas cancer. Current scientific and translational efforts in his laboratory include the evaluation of the radiosensitizing effects of Losartan in orthotopic pancreatic cancer tumor models and new imaging biomarkers, such as Zinc magnetic resonance imaging, for early and accurate detection of pancreatic ductal adenocarcinoma.
Dr. Qadan is also interested in clinical outcomes health services research and leads a large group of researchers who focus on methods to collect, analyze, and improve outcomes related to cancer surgery at the institutional and national level. His projects have earned national recognition in the form of multiple prizes and awards over the last few months.
Dr. Qadan is an active clinical investigator in several high impact clinical trials. He is a principal investigator on a prehabilitation study entitled "Pilot Study of a Multimodal Prehabilitation Pancreatic Cancer Program" where he enrolls patients in an exercise and nutrition program to improve their outcomes during treatment for pancreatic cancer.
Dr. Qadan is actively involved in many National societies and holds active leadership roles in several organizations. He has over 200 peer-reviewed scientific articles as well as several book chapters and scientific abstracts. Dr. Qadan is an active member of the Gastrointestinal Malignancies Program at the Dana-Farber/Harvard Cancer Center.
If you are interested in making a direct donation, please indicate the "Qadan Liver and Pancreas Research Fund". Donations are tax-deductible and handled by my colleague Ms. Meagan Coons of the MGH Development Office, 125 Nashua St, Suite 540, Boston, MA 02114. All donations are so greatly appreciated.